Please login to the form below

Not currently logged in
Email:
Password:

Launch date for doctors' licences announced

From 16 November all doctors in the UK will need a licence in order to practise medicine, the GMC has announced

From 16 November all doctors in the UK will need a licence in order to practise medicine, the GMC has announced.  

The announcement of the launch date is seen as a significant milestone in medical regulation as currently the only stipulation is that a doctor has to be registered with the General Medical Council. Holding a licence will be required in addition to their GMC registration. Some doctors however, such as academics or researchers, won't need a licence to practise and are therefore choosing to hold registration without a licence.

GMC Chair Professor Peter Rubin said: "We have received a good response to the licensing campaign, having asked 225,000 doctors whether they want a licence to practise. So far, almost 50 per cent of doctors have responded, with the vast majority choosing to take a licence."

"The introduction of the licence is the first step towards a new system called revalidation, the process through which doctors will be asked periodically to demonstrate that they are up to date and fit to practise in the job they do."

"Licensing is a major milestone. The next stage is to implement revalidation. Once we have the results back from the pilots we will be in a position to draw together a more coherent revalidation timetable."

The GMC has produced a guide, Revalidation: Information for Doctors and Frequently Asked Questions, which aims to answer doctors' queries about revalidation.

15th June 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics